Mckesson Corp
NYSE:MCK
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
439.47
630.38
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mckesson Corp
Revenue
Mckesson Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Mckesson Corp
NYSE:MCK
|
Revenue
$330.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
||
Cardinal Health Inc
NYSE:CAH
|
Revenue
$224.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
||
Henry Schein Inc
NASDAQ:HSIC
|
Revenue
$12.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
||
Adapthealth Corp
NASDAQ:AHCO
|
Revenue
$4.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Patterson Companies Inc
NASDAQ:PDCO
|
Revenue
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
||
Cencora Inc
NYSE:COR
|
Revenue
$294B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
Mckesson Corp
Revenue Breakdown
Breakdown by Geography
Mckesson Corp
Breakdown by Segments
Mckesson Corp
Total Revenue:
309B
USD
|
United States Pharmaceutical:
278.7B
USD
|
International:
14.1B
USD
|
Medical-Surgical Solutions:
11.3B
USD
|
Prescription Technology Solutions:
4.8B
USD
|
Mckesson Corp
Glance View
McKesson Corporation stands as a cornerstone of the healthcare industry, playing a vital role in the distribution and management of pharmaceuticals and healthcare services. Founded in 1833, the company has evolved from its early days as a drug wholesaler into a formidable player providing critical support in the supply chain for hospitals, pharmacies, and healthcare providers across the United States and beyond. With a strong commitment to enhancing patient care, McKesson offers a comprehensive range of services, including the distribution of prescription medications, health information technology, and pharmacy management. This diverse portfolio not only strengthens the company’s market position but also underscores its commitment to improving healthcare outcomes. For investors, McKesson represents both a growth opportunity and a stable investment in the ever-evolving healthcare landscape. The company's robust revenue streams, driven by increasing demand for pharmaceuticals and innovative healthcare solutions, position it favorably for long-term growth, especially in light of the ongoing transformations in healthcare delivery. Furthermore, McKesson's strategic partnerships and acquisitions amplify its capabilities, enabling it to tackle emerging market trends. With a history of resilience and adaptation, McKesson is well-positioned to navigate challenges in the healthcare sector, making it an attractive proposition for those seeking a reliable investment in a vital industry.
See Also
What is Mckesson Corp's Revenue?
Revenue
330.2B
USD
Based on the financial report for Sep 30, 2024, Mckesson Corp's Revenue amounts to 330.2B USD.
What is Mckesson Corp's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Mckesson Corp have been 10% over the past three years , 8% over the past five years , and 8% over the past ten years .